Iovance Biotherapeutics Signs New Headquarters Lease and Terminates Previous Lease Agreement
Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a Delaware-based biotechnology company, has recently announced significant changes in its office locations and lease agreements. On November 15, 2024, the company finalized a sublease agreement with Vaxcyte, Inc. for Suite 100 at 825 Industrial Road, San Carlos, California. This move comes as part of the company’s strategic initiatives to […]
More Stories
Trump Endorses Steve Hilton in Heated Race for California Governor
By Jill McLaughlin Republican Steve Hilton captured President Donald Trump’s endorsement on April 5 in his quest to become the...
Race to Secure Iran Cease-Fire Intensifies as Trump Ultimatum Ticks Down
By Chris Summers Efforts to revive cease-fire negotiations between the United States and Iran intensified on April 6 as regional...
Is Resume Genius Legit? Pricing, Features, and Cancellation Policy
Whether you are a working professional or a student, in your life, you must have searched for an online resume...
How Career-Focused College Scholarships for Students Help Today’s Graduates Afford College and Hit the Workforce Job-Ready
College is a big investment, and students want more than a diploma. They want a fair price and a clear...
Trump Threatens to Target Iran’s Bridges, Power Plants on April 7 if Strait of Hormuz Not Reopened
By Jacki Thrapp U.S. President Donald Trump has threatened to target Iran’s power plants and bridges on April 7 if...
Iran Says It Will Retaliate If Civilian Infrastructure Is Targeted Amid Trump Deadline
By Jack Phillips Iranian officials on Sunday said the country would carry out more forceful attacks on targets if the...